An Open-Label, Multicenter, Multinational Study of Lacosamide as First Add-On Anti-epileptic Drug (AED) Treatment in Subjects With Partial-Onset Seizures
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Acronyms VERSA
- Sponsors UCB
- 25 Apr 2015 Results presented at the 67th Annual Meeting of the American Academy of Neurology.
- 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2013 Planned end date changed from 1 Aug 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.